NEW YORK (GenomeWeb News) – Clinical Data today reported that its fiscal fourth-quarter revenues doubled year over year as its quarterly net loss grew by 62 percent.

Revenue for the three months ended March 31 climbed 103 percent to $3.2 million from $1.6 million in the comparable period of 2008. The company attributed the increase to the expansion of its PGxHealth sales and marketing force and increased payor coverage during the last 18 months.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.